Immunology Drug Market to Reach USD 186.80 Billion by 2030, Growing at 8.1% CAGR

◉ Immunology Drug Market Set to Reach USD 186.80 Billion by 2030, Driven by Rising Autoimmune Diseases and Biologic Innovations

The global immunology drug market, valued at USD 108.29 billion in 2023, is projected to grow at a compound annual growth rate (CAGR) of 8.1%, reaching approximately USD 186.80 billion by 2030.

Explore the market further-request a sample report today: https://www.maximizemarketresearch.com/request-sample/125678/

◉ Immunology Drug Market Dynamics

The increasing prevalence of autoimmune diseases, influenced by environmental factors such as exposure to toxic chemicals, stress, dietary components, and infections, is a significant driver of market growth. According to the National Stem Cell Foundation, nearly 4% of the global population is affected by one or more of over 80 different autoimmune diseases.

Additionally, the market is experiencing growth due to the introduction of biosimilars. For instance, in February 2021, Sandoz Canada launched Hyrimoz, a biosimilar to adalimumab (HUMIRA), approved for treating autoimmune diseases such as rheumatoid arthritis and Crohn's disease.

◉ Immunology Drug Market Competitive Landscape

Key players in the immunology drug market include AbbVie Inc., Janssen Global Services, LLC, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Amgen Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Merck & Co., Inc., and GlaxoSmithKline plc. These companies are focusing on research and development, strategic partnerships, and product launches to strengthen their market positions.​

Request a sample report for more insights and details today: https://www.maximizemarketresearch.com/request-sample/125678/

◉ Immunology Drug Market Regional Demand

North America has established itself as the dominant region in the global immunology market, with an estimated market share of 40.7% in 2025. This dominance is attributed to the strong presence of pharmaceutical companies and a growing biotechnology industry in the region. ​
Coherent Market Insights

◉ Country-Specific Developments

Vietnam: Opportunities in Immunology Drug Market

Vietnam's healthcare sector is witnessing growth, presenting opportunities for immunology drug manufacturers to expand their presence and address the increasing demand for autoimmune disease treatments.​

Thailand: Trends in Immunology Drug Adoption

Thailand is experiencing an uptick in the adoption of immunology drugs, driven by enhanced healthcare infrastructure and growing awareness of autoimmune diseases among the population.​

Japan: Consolidation in Immunology Sector

Japanese pharmaceutical companies are engaging in strategic mergers and acquisitions to consolidate their positions in the immunology drug market, aiming to enhance research capabilities and expand product portfolios.​

South Korea: Updation of Immunology Treatments

South Korea is updating its immunology treatment protocols, incorporating advanced biologic therapies to improve patient outcomes in autoimmune diseases.​

Singapore: Opportunities in Immunology Research

Singapore's Biosyngen has announced a strategic collaboration with the Agency for Science, Technology and Research (A*STAR) to enhance autoimmune therapy research, aiming to develop innovative treatments for autoimmune diseases. ​

For full access to the data, request a sample report now:
https://www.maximizemarketresearch.com/request-sample/125678/

United States: Growth in Immunology Drug Investments

The United States is witnessing significant investments in the immunology drug sector, with companies focusing on expanding their biologic drug portfolios to cater to the rising prevalence of autoimmune conditions.​

China: Trends in Immunology Drug Development

Chinese biotech firms are making notable strides in immunology drug development, contributing to the global market with innovative therapies and biosimilars.​

Europe: Consolidation in Immunology Market

European pharmaceutical companies are pursuing consolidation strategies through mergers and acquisitions to strengthen their immunology drug offerings and enhance market competitiveness.​

◉ Immunology Drug Market Segmentation

by Drug Class Type

Monoclonal Antibody
Fusion Proteins
Immunosuppressant
Polyclonal Antibody

The Immunology Drug Market is divided into four segments based on drug class type: monoclonal antibodies, fusion proteins, immunosuppressants, and polyclonal antibodies. The Immunology Drug Market dominates the monoclonal Antibody sector, accounting for 39.1% of the market in 2023. The dominance is due to the documented clinical efficacy of monoclonal antibodies like adalimumab and rituximab in the treatment of rare and chronic disorders, as well as autoimmune diseases. In addition to the increased number of approvals for these medications.

by Disease Condition

Rheumatoid Arthritis
Psoriatic Arthritis
Plaque Psoriasis
Inflammatory Bowel Disease
Prophylaxis of Organ Rejection

by Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Want market insights? Read the summary of the research report for essential data: https://www.maximizemarketresearch.com/market-report/immunology-drug-market/125678/

◉ Recent Mergers and Acquisitions

Lupin Limited: In September 2020, Lupin launched generic rheumatoid arthritis drug, Leflunomide, in the U.S., expanding its immunology portfolio.

◉ Conclusion

The global immunology drug market is on a robust growth trajectory, driven by the rising prevalence of autoimmune diseases and advancements in biologic therapies. Strategic initiatives by key players, including product launches and expansions, are expected to further propel market growth in the coming years.

◉ Get Market Research Latest Trends:

Global Granulocyte Macrophage Colony Stimulating Factor Market https://www.maximizemarketresearch.com/market-report/global-granulocyte-macrophage-colony-stimulating-factor-market/69429/

Global Ankle-Brachial Index Measurement Market https://www.maximizemarketresearch.com/market-report/global-ankle-brachial-index-measurement-market/84325/

Global Rectopexy Mesh and Grafts Market https://www.maximizemarketresearch.com/market-report/global-rectopexy-mesh-and-grafts-market/94764/

Global Lesch-Nyhan Syndrome Market https://www.maximizemarketresearch.com/market-report/global-lesch-nyhan-syndrome-market/91116/

Zonisamide Market https://www.maximizemarketresearch.com/market-report/zonisamide-market/148295/

Global Patients Repositioning and Offloading Device Market https://www.maximizemarketresearch.com/market-report/patients-repositioning-and-offloading-device-market/123289/

global N95 Mask Market https://www.maximizemarketresearch.com/market-report/global-n95-mask-market/105931/

Global Hypothermia Cap Market https://www.maximizemarketresearch.com/market-report/global-hypothermia-cap-market/107669/

Global Podiatry Equipment Market https://www.maximizemarketresearch.com/market-report/global-podiatry-equipment-market/73791/

Global Metachromatic Leukodystrophy Treatment Market https://www.maximizemarketresearch.com/market-report/global-metachromatic-leukodystrophy-treatment-market-industry-analysis-and-forecast-2020-2026-by-type-treatment-type-sales-channel-and-region/111959/

Global Rheumatoid Arthritis Diagnosis Market https://www.maximizemarketresearch.com/market-report/global-rheumatoid-arthritis-diagnosis-market/112472/

Global Amniotic Products Market https://www.maximizemarketresearch.com/market-report/global-amniotic-products-market/116700/

Global Bone Marrow Aspirate Concentrates (BMAC) Market https://www.maximizemarketresearch.com/market-report/global-bone-marrow-aspirate-concentrates-bmac-market/37078/

Global Dialysis Disposable Devices Market https://www.maximizemarketresearch.com/market-report/global-dialysis-disposable-devices-market/106788/

Global Uro-Gynaecological Surgical Devices Market https://www.maximizemarketresearch.com/market-report/global-uro-gynaecological-surgical-devices-market/82678/

Contact Maximize Market Research:

3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656

About Maximize Market Research:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

This release was published on openPR.